BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18369966)

  • 1. Controlling the release of proteins/peptides via the pulmonary route.
    Shoyele SA
    Methods Mol Biol; 2008; 437():141-8. PubMed ID: 18369966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes.
    Haidar ZS; Hamdy RC; Tabrizian M
    Biomaterials; 2008 Mar; 29(9):1207-15. PubMed ID: 18076987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable hydrogels for time-controlled release of tethered peptides or proteins.
    Brandl F; Hammer N; Blunk T; Tessmar J; Goepferich A
    Biomacromolecules; 2010 Feb; 11(2):496-504. PubMed ID: 20095560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative delivery systems for peptides and proteins as drugs.
    Eppstein DA; Longenecker JP
    Crit Rev Ther Drug Carrier Syst; 1988; 5(2):99-139. PubMed ID: 3052876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
    Shoyele SA; Slowey A
    Int J Pharm; 2006 May; 314(1):1-8. PubMed ID: 16563674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in protein and peptide delivery by noninvasive routes.
    Wearley LL
    Crit Rev Ther Drug Carrier Syst; 1991; 8(4):331-94. PubMed ID: 1769066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic treatment by inhalation of macromolecules--principles, problems, and examples.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():53-79. PubMed ID: 19218633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
    Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
    Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
    Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A
    J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to enhance pulmonary delivery of proteins and peptides.
    Scheuch G; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):615-25. PubMed ID: 18204175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
    Sahni JK; Chopra S; Ahmad FJ; Khar RK
    J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microencapsulation peptide and protein drugs delivery system.
    Dai C; Wang B; Zhao H
    Colloids Surf B Biointerfaces; 2005 Mar; 41(2-3):117-20. PubMed ID: 15737536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.
    O'Hagan DT; Illum L
    Crit Rev Ther Drug Carrier Syst; 1990; 7(1):35-97. PubMed ID: 2257636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Delivery--Select Biosciences Inaugural Summit. 2-4 September 2009, London, UK.
    Schiffelers R
    IDrugs; 2009 Nov; 12(11):679-82. PubMed ID: 19844850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalative nanomedicine--opportunities and challenges.
    Bur M; Henning A; Hein S; Schneider M; Lehr CM
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():137-43. PubMed ID: 19558246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commercial challenges of protein drug delivery.
    Brown LR
    Expert Opin Drug Deliv; 2005 Jan; 2(1):29-42. PubMed ID: 16296733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternized chitosan (QCS)/poly (aspartic acid) nanoparticles as a protein drug-delivery system.
    Wang Tw; Xu Q; Wu Y; Zeng Aj; Li M; Gao H
    Carbohydr Res; 2009 May; 344(7):908-14. PubMed ID: 19303066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable polymers for controlled release of peptides and proteins.
    Hutchinson FG; Furr BJ
    Horiz Biochem Biophys; 1989; 9():111-29. PubMed ID: 2656473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.